Risk factors for polypharmacy in older adults in a primary care setting: a cross-sectional study
Suleyman Ersoy,1 Velittin Selcuk Engin2 1Department of Family Medicine, Faculty of Medicine, Karabuk University, Karabuk, Turkey; 2Melekhatun Family Practice Center, Ministry of Health, Istanbul 34340, Turkey Purpose: Polypharmacy (PP) is a clinical challenge in older adults. Therefore, assessment...
Guardado en:
Autores principales: | Ersoy S, Engin VS |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0c884f47c25e4ee4b21e4452c056f632 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Polypharmacy in the HIV-infected older adult population
por: Gleason LJ, et al.
Publicado: (2013) -
Polypharmacy Is Associated with Frailty, Nutritional Risk and Chronic Disease in Chilean Older Adults: Remarks from PIEI-ES Study
por: Arauna D, et al.
Publicado: (2020) -
Expert-based medication reviews to reduce polypharmacy in older patients in primary care: a northern-Italian cluster-randomised controlled trial
por: Angelika Mahlknecht, et al.
Publicado: (2021) -
Polypharmacy in older adults with human immunodeficiency virus infection compared with the general population
por: Gimeno-Gracia M, et al.
Publicado: (2016) -
The Changes in Medication Prescribing Among the Older People with Cognitive Impairment in the Acute Care Setting
por: Ruangritchankul S, et al.
Publicado: (2020)